$TKMR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arbutus Biopharma Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Arbutus Biopharma Corp. Get notifications about new insider transactions in Arbutus Biopharma Corp for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | TKMR | Arbutus Biopharma ... | Picchio Gaston | Chief Development O ... | Option Exercise | A | 4.33 | 250,000 | 1,082,500 | 250,000 | |
| Feb 17 2021 | TKMR | Arbutus Biopharma ... | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 4.33 | 250,000 | 1,082,500 | 250,000 | |
| Feb 17 2021 | TKMR | Arbutus Biopharma ... | Howard Elizabeth | Chief Compliance Of ... | Option Exercise | A | 4.33 | 200,000 | 866,000 | 200,000 | |
| Feb 17 2021 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Option Exercise | A | 4.33 | 290,000 | 1,255,700 | 290,000 | |
| Feb 17 2021 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Option Exercise | A | 4.33 | 290,000 | 1,255,700 | 290,000 | |
| Feb 10 2021 | TKMR | Arbutus Biopharma ... | McElhaugh Michael J. | Chief Business Offi ... | Sell | S | 5.00 | 20,000 | 100,000 | 1,307,457 | 1.3 M to 1.3 M (-1.51 %) |
| Dec 16 2020 | TKMR | Arbutus Biopharma ... | McElhaugh Michael J. | Chief Business Offi ... | Sell | S | 5.00 | 10,000 | 50,032 | 1,327,457 | 1.3 M to 1.3 M (-0.75 %) |
| Dec 16 2020 | TKMR | Arbutus Biopharma ... | McElhaugh Michael J. | Chief Business Offi ... | Sell | S | 5.00 | 30,000 | 150,000 | 1,337,457 | 1.4 M to 1.3 M (-2.19 %) |
| Sep 25 2020 | TKMR | Arbutus Biopharma ... | Picchio Gaston | Chief Development O ... | Option Exercise | A | 3.35 | 50,000 | 167,500 | 50,000 | |
| Sep 25 2020 | TKMR | Arbutus Biopharma ... | Collier William H. | President and CEO | Option Exercise | A | 3.35 | 70,000 | 234,500 | 70,000 | |
| Jul 27 2020 | TKMR | Arbutus Biopharma ... | McElhaugh Michael J. | Chief Business Offi ... | Sell | S | 5.01 | 20,000 | 100,200 | 1,367,457 | 1.4 M to 1.4 M (-1.44 %) |
| Jun 01 2020 | TKMR | Arbutus Biopharma ... | Meyers James R | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
| Jun 01 2020 | TKMR | Arbutus Biopharma ... | HENRIQUES RICHARD C JR | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
| Jun 01 2020 | TKMR | Arbutus Biopharma ... | Collier William H. | President and CEO | Option Exercise | A | 3.35 | 262,313 | 878,749 | 262,313 | |
| Jun 01 2020 | TKMR | Arbutus Biopharma ... | Torti Frank | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
| Jun 01 2020 | TKMR | Arbutus Biopharma ... | Cheng Andrew | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
| Jun 01 2020 | TKMR | Arbutus Biopharma ... | MANCHESTER KEITH S | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
| Jun 01 2020 | TKMR | Arbutus Biopharma ... | BURGESS DANIEL D | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
| Feb 19 2020 | TKMR | Arbutus Biopharma ... | Howard Elizabeth | Chief Compliance Of ... | Option Exercise | A | 3.35 | 79,500 | 266,325 | 79,500 | |
| Feb 19 2020 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Option Exercise | A | 3.35 | 250,000 | 837,500 | 250,000 | |
| Feb 19 2020 | TKMR | Arbutus Biopharma ... | Picchio Gaston | Chief Development O ... | Option Exercise | A | 3.35 | 150,000 | 502,500 | 150,000 | |
| Feb 19 2020 | TKMR | Arbutus Biopharma ... | Collier William H. | President and CEO | Option Exercise | A | 3.35 | 367,087 | 1,229,741 | 367,087 | |
| Feb 19 2020 | TKMR | Arbutus Biopharma ... | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 3.35 | 100,000 | 335,000 | 100,000 | |
| Feb 19 2020 | TKMR | Arbutus Biopharma ... | McElhaugh Michael J. | Chief Business Offi ... | Option Exercise | A | 3.35 | 200,000 | 670,000 | 200,000 | |
| Aug 20 2019 | TKMR | Arbutus Biopharma ... | Cheng Andrew | Director | Option Exercise | A | 1.50 | 60,000 | 90,000 | 60,000 | |
| Aug 20 2019 | TKMR | Arbutus Biopharma ... | POTTER MYRTLE S | Director | Option Exercise | A | 1.50 | 22,000 | 33,000 | 22,000 | |
| Aug 20 2019 | TKMR | Arbutus Biopharma ... | BURGESS DANIEL D | Director | Option Exercise | A | 1.50 | 22,000 | 33,000 | 22,000 | |
| Aug 20 2019 | TKMR | Arbutus Biopharma ... | Meyers James R | Director | Option Exercise | A | 1.50 | 22,000 | 33,000 | 22,000 | |
| Aug 20 2019 | TKMR | Arbutus Biopharma ... | MANCHESTER KEITH S | Director | Option Exercise | A | 1.50 | 22,000 | 33,000 | 22,000 | |
| Aug 20 2019 | TKMR | Arbutus Biopharma ... | HENRIQUES RICHARD C JR | Director | Option Exercise | A | 1.50 | 22,000 | 33,000 | 22,000 | |
| Aug 20 2019 | TKMR | Arbutus Biopharma ... | Torti Frank | Director | Option Exercise | A | 1.50 | 22,000 | 33,000 | 22,000 | |
| Jun 26 2019 | TKMR | Arbutus Biopharma ... | Collier William H. | President and CEO | Option Exercise | A | 2.18 | 1,112,000 | 2,424,160 | 1,112,000 | |
| Dec 13 2018 | TKMR | Arbutus Biopharma ... | VandenEnden Koert | Chief Accounting Of ... | Option Exercise | A | 4.44 | 7,500 | 33,300 | 7,500 | |
| Nov 30 2018 | TKMR | Arbutus Biopharma ... | Murray Mark J. | Director | Option Exercise | M | 1.35 | 25,000 | 33,750 | 0 | |
| Nov 30 2018 | TKMR | Arbutus Biopharma ... | Murray Mark J. | Director | Buy | M | 1.35 | 25,000 | 33,750 | 341,396 | 316.4 K to 341.4 K (+7.90 %) |
| Nov 27 2018 | TKMR | Arbutus Biopharma ... | Torti Frank | Director | Option Exercise | A | 4.72 | 44,000 | 207,680 | 44,000 | |
| Oct 22 2018 | TKMR | Arbutus Biopharma ... | POTTER MYRTLE S | Director | Option Exercise | A | 4.71 | 44,000 | 207,240 | 44,000 | |
| Oct 22 2018 | TKMR | Arbutus Biopharma ... | Meyers James R | Director | Option Exercise | A | 4.71 | 44,000 | 207,240 | 44,000 | |
| Oct 10 2018 | TKMR | Arbutus Biopharma ... | Picchio Gaston | Chief Development O ... | Option Exercise | A | 9.38 | 200,000 | 1,876,000 | 200,000 | |
| Aug 14 2018 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Sell | S | 9.51 | 4,250 | 40,436 | 1,499,153 | 1.5 M to 1.5 M (-0.28 %) |
| Jul 13 2018 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Sell | S | 10.00 | 10,000 | 100,000 | 1,503,403 | 1.5 M to 1.5 M (-0.66 %) |
| Jul 10 2018 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Sell | S | 8.91 | 10,000 | 89,060 | 1,513,403 | 1.5 M to 1.5 M (-0.66 %) |
| Jul 10 2018 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Sell | S | 8.45 | 10,000 | 84,500 | 1,523,403 | 1.5 M to 1.5 M (-0.65 %) |
| Jul 06 2018 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Sell | S | 8.40 | 10,000 | 84,000 | 1,533,403 | 1.5 M to 1.5 M (-0.65 %) |
| Jul 06 2018 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Sell | S | 8.00 | 10,000 | 80,000 | 1,543,403 | 1.6 M to 1.5 M (-0.64 %) |
| Jun 25 2018 | TKMR | Arbutus Biopharma ... | HENRIQUES RICHARD C JR | Director | Option Exercise | A | 6.75 | 22,000 | 148,500 | 22,000 | |
| Jun 22 2018 | TKMR | Arbutus Biopharma ... | CONRAD HERBERT J | Director | Option Exercise | A | 6.75 | 22,000 | 148,500 | 22,000 | |
| Jun 22 2018 | TKMR | Arbutus Biopharma ... | CONRAD HERBERT J | Director | Option Exercise | A | 6.75 | 22,000 | 148,500 | 22,000 | |
| Jun 22 2018 | TKMR | Arbutus Biopharma ... | MANCHESTER KEITH S | Director | Option Exercise | A | 6.75 | 22,000 | 148,500 | 22,000 | |
| Jun 22 2018 | TKMR | Arbutus Biopharma ... | Ramaswamy Vivek | Director | Option Exercise | A | 6.75 | 22,000 | 148,500 | 22,000 | |
| Jun 22 2018 | TKMR | Arbutus Biopharma ... | BURGESS DANIEL D | Director | Option Exercise | A | 6.75 | 22,000 | 148,500 | 22,000 | |
| Jun 21 2018 | TKMR | Arbutus Biopharma ... | HASTINGS DAVID C | Chief Financial Off ... | Option Exercise | A | 6.75 | 200,000 | 1,350,000 | 200,000 | |
| Apr 18 2018 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Option Exercise | A | 5.20 | 160,000 | 832,000 | 160,000 | |
| Apr 17 2018 | TKMR | Arbutus Biopharma ... | Murray Mark J. | President & CEO | Option Exercise | M | 0.35 | 27,007 | 9,560 | 0 | |
| Apr 17 2018 | TKMR | Arbutus Biopharma ... | Murray Mark J. | President & CEO | Option Exercise | A | 5.20 | 418,187 | 2,174,572 | 418,187 | |
| Apr 17 2018 | TKMR | Arbutus Biopharma ... | Murray Mark J. | President & CEO | Buy | M | 0.35 | 27,007 | 9,560 | 316,396 | 289.4 K to 316.4 K (+9.33 %) |
| Apr 17 2018 | TKMR | Arbutus Biopharma ... | VandenEnden Koert | Interim CFO | Option Exercise | A | 5.20 | 25,000 | 130,000 | 25,000 | |
| Apr 17 2018 | TKMR | Arbutus Biopharma ... | Symonds William T. | Chief Development O ... | Option Exercise | A | 5.20 | 30,000 | 156,000 | 30,000 | |
| Apr 17 2018 | TKMR | Arbutus Biopharma ... | Howard Elizabeth | Exec. VP & General ... | Option Exercise | A | 5.20 | 150,000 | 780,000 | 150,000 | |
| Jan 16 2018 | TKMR | Arbutus Biopharma ... | SVF Investments (UK) Ltd | 10% Owner | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
| Jan 16 2018 | TKMR | Arbutus Biopharma ... | Dexxon Holdings Ltd. | 10% Owner | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
| Jan 16 2018 | TKMR | Arbutus Biopharma ... | QVT Associates GP LLC | Director | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
| Jan 16 2018 | TKMR | Arbutus Biopharma ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
| Jan 16 2018 | TKMR | Arbutus Biopharma ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
| Jan 16 2018 | TKMR | Arbutus Biopharma ... | Lo Andrew | 10% Owner | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
| Jan 16 2018 | TKMR | Arbutus Biopharma ... | Roivant Sciences Ltd. | 10% Owner | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
| Jan 16 2018 | TKMR | Arbutus Biopharma ... | Machado Patrick | 10% Owner | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
| Oct 18 2017 | TKMR | Arbutus Biopharma ... | Dexxon Holdings Ltd. | 10% Owner | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
| Oct 17 2017 | TKMR | Arbutus Biopharma ... | QVT Associates GP LLC | Director | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
| Oct 17 2017 | TKMR | Arbutus Biopharma ... | SVF Investments (UK) Ltd | 10% Owner | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
| Oct 17 2017 | TKMR | Arbutus Biopharma ... | VIKING GLOBAL INVESTORS LP | 10% Owner | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
| Oct 17 2017 | TKMR | Arbutus Biopharma ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
| Oct 17 2017 | TKMR | Arbutus Biopharma ... | Lo Andrew | 10% Owner | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
| Oct 17 2017 | TKMR | Arbutus Biopharma ... | Roivant Sciences Ltd. | 10% Owner | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
| Oct 17 2017 | TKMR | Arbutus Biopharma ... | Machado Patrick | 10% Owner | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
| Oct 05 2017 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Sell | S | 8.00 | 10,000 | 80,000 | 1,553,403 | 1.6 M to 1.6 M (-0.64 %) |
| Aug 17 2017 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Sell | S | 3.68 | 20,000 | 73,500 | 171,412 | 191.4 K to 171.4 K (-10.45 %) |
| Aug 17 2017 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Sell | S | 3.75 | 10,000 | 37,500 | 191,412 | 201.4 K to 191.4 K (-4.96 %) |
| Jun 23 2017 | TKMR | Arbutus Biopharma ... | MANCHESTER KEITH S | Director | Option Exercise | A | 3.55 | 22,000 | 78,100 | 22,000 | |
| Jun 23 2017 | TKMR | Arbutus Biopharma ... | Ramaswamy Vivek | Director | Option Exercise | A | 3.55 | 22,000 | 78,100 | 22,000 | |
| Jun 23 2017 | TKMR | Arbutus Biopharma ... | KARBE FRANK | Director | Option Exercise | A | 3.55 | 22,000 | 78,100 | 22,000 | |
| Jun 22 2017 | TKMR | Arbutus Biopharma ... | HENRIQUES RICHARD C JR | Director | Option Exercise | A | 3.55 | 22,000 | 78,100 | 22,000 | |
| Jun 22 2017 | TKMR | Arbutus Biopharma ... | CONRAD HERBERT J | Director | Option Exercise | A | 3.55 | 22,000 | 78,100 | 22,000 | |
| Jun 22 2017 | TKMR | Arbutus Biopharma ... | BURGESS DANIEL D | Director | Option Exercise | A | 3.55 | 22,000 | 78,100 | 22,000 | |
| Apr 05 2017 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Option Exercise | A | 3.15 | 150,000 | 472,500 | 150,000 | |
| Apr 05 2017 | TKMR | Arbutus Biopharma ... | Murray Mark J. | President & CEO | Option Exercise | A | 3.15 | 450,000 | 1,417,500 | 450,000 | |
| Apr 05 2017 | TKMR | Arbutus Biopharma ... | Lutwyche Peter | Chief Technology Of ... | Option Exercise | A | 3.15 | 125,000 | 393,750 | 125,000 | |
| Apr 05 2017 | TKMR | Arbutus Biopharma ... | Howard Elizabeth | Exec. VP & General ... | Option Exercise | A | 3.15 | 125,000 | 393,750 | 125,000 | |
| Apr 05 2017 | TKMR | Arbutus Biopharma ... | Cousins Bruce | EVP & Chief Financi ... | Option Exercise | A | 3.15 | 200,000 | 630,000 | 200,000 | |
| Apr 05 2017 | TKMR | Arbutus Biopharma ... | Symonds William T. | Chief Development O ... | Option Exercise | A | 3.15 | 50,000 | 157,500 | 50,000 | |
| Mar 27 2017 | TKMR | Arbutus Biopharma ... | BURGESS DANIEL D | Director | Option Exercise | A | 3.15 | 50,000 | 157,500 | 50,000 | |
| Aug 18 2016 | TKMR | Arbutus Biopharma ... | Abrams Michael J. | Managing Director | Option Exercise | M | 0.35 | 13,503 | 4,665 | 0 | |
| Aug 18 2016 | TKMR | Arbutus Biopharma ... | Abrams Michael J. | Managing Director | Option Exercise | M | 0.35 | 675 | 233 | 0 | |
| Aug 18 2016 | TKMR | Arbutus Biopharma ... | Abrams Michael J. | Managing Director | Buy | M | 0.35 | 14,178 | 4,898 | 42,097 | 27.9 K to 42.1 K (+50.78 %) |
| Jun 20 2016 | TKMR | Arbutus Biopharma ... | Murray Mark J. | President & CEO | Option Exercise | X | 2.57 | 5,000 | 12,844 | 0 | |
| Jun 20 2016 | TKMR | Arbutus Biopharma ... | Murray Mark J. | President & CEO | Buy | X | 2.57 | 5,000 | 12,844 | 289,389 | 284.4 K to 289.4 K (+1.76 %) |
| Jun 07 2016 | TKMR | Arbutus Biopharma ... | Ramaswamy Vivek | Director | Option Exercise | A | 3.99 | 7,500 | 29,925 | 7,500 | |
| Jun 07 2016 | TKMR | Arbutus Biopharma ... | MANCHESTER KEITH S | Director | Option Exercise | A | 3.99 | 7,500 | 29,925 | 7,500 | |
| Jun 07 2016 | TKMR | Arbutus Biopharma ... | HENRIQUES RICHARD C JR | Director | Option Exercise | A | 3.99 | 7,500 | 29,925 | 7,500 | |
| Jun 07 2016 | TKMR | Arbutus Biopharma ... | CONRAD HERBERT J | Director | Option Exercise | A | 3.99 | 7,500 | 29,925 | 7,500 | |
| Jun 07 2016 | TKMR | Arbutus Biopharma ... | KARBE FRANK | Director | Option Exercise | A | 3.99 | 7,500 | 29,925 | 7,500 | |
| Mar 17 2016 | TKMR | Arbutus Biopharma ... | Symonds William T. | Chief Development O ... | Option Exercise | A | 3.94 | 25,000 | 98,500 | 25,000 | |
| Mar 17 2016 | TKMR | Arbutus Biopharma ... | Howard Elizabeth | Exec. VP & General ... | Option Exercise | A | 3.94 | 120,000 | 472,800 | 120,000 | |
| Mar 17 2016 | TKMR | Arbutus Biopharma ... | Sofia Michael J. | Chief Scientific Of ... | Option Exercise | A | 3.94 | 100,000 | 394,000 | 100,000 | |
| Mar 17 2016 | TKMR | Arbutus Biopharma ... | Murray Mark J. | President & CEO | Option Exercise | A | 3.94 | 450,000 | 1,773,000 | 450,000 | |
| Mar 17 2016 | TKMR | Arbutus Biopharma ... | Lutwyche Peter | Chief Tech. Operati ... | Option Exercise | A | 3.94 | 60,000 | 236,400 | 60,000 | |
| Mar 17 2016 | TKMR | Arbutus Biopharma ... | Kowalski Mark | Sr VP & Chief Medic ... | Option Exercise | A | 3.94 | 85,000 | 334,900 | 85,000 | |
| Mar 17 2016 | TKMR | Arbutus Biopharma ... | Cousins Bruce | Exec VP & CFO | Option Exercise | A | 3.94 | 145,000 | 571,300 | 145,000 | |
| Mar 17 2016 | TKMR | Arbutus Biopharma ... | Abrams Michael J. | Managing Director | Option Exercise | A | 3.94 | 50,000 | 197,000 | 50,000 | |
| Dec 22 2015 | TKMR | Arbutus Biopharma ... | Murray Mark J. | President & CEO | Option Exercise | A | 17.57 | 100,000 | 1,757,000 | 100,000 | |
| Dec 22 2015 | TKMR | Arbutus Biopharma ... | Cousins Bruce | Exec VO & CFO | Option Exercise | A | 17.57 | 75,000 | 1,317,750 | 75,000 | |
| Dec 22 2015 | TKMR | Arbutus Biopharma ... | Abrams Michael J. | Exec. VP & Chief Di ... | Option Exercise | A | 17.57 | 35,000 | 614,950 | 35,000 | |
| Sep 15 2015 | TKMR | Arbutus Biopharma ... | Murray Mark J. | President & CEO | Option Exercise | M | 0.44 | 219,428 | 97,514 | 0 | |
| Sep 15 2015 | TKMR | Arbutus Biopharma ... | Murray Mark J. | President & CEO | Buy | M | 0.44 | 219,428 | 97,514 | 284,389 | 65 K to 284.4 K (+337.78 %) |
| Sep 15 2015 | TKMR | Arbutus Biopharma ... | Abrams Michael J. | Managing Director | Option Exercise | M | 0.44 | 17,044 | 7,574 | 0 | |
| Sep 15 2015 | TKMR | Arbutus Biopharma ... | Abrams Michael J. | Managing Director | Buy | M | 0.44 | 17,044 | 7,574 | 27,919 | 10.9 K to 27.9 K (+156.73 %) |
| Aug 26 2015 | TKMR | Arbutus Biopharma ... | HENRIQUES RICHARD C JR | Director | Buy | P | 6.95 | 1,000 | 6,950 | 1,000 | 0 to 1,000 |
| Aug 14 2015 | TKMR | Arbutus Biopharma ... | Ramaswamy Vivek | Director | Option Exercise | A | 9.11 | 7,500 | 68,325 | 7,500 | |
| Aug 14 2015 | TKMR | Arbutus Biopharma ... | MANCHESTER KEITH S | Director | Option Exercise | A | 9.11 | 7,500 | 68,325 | 7,500 | |
| Aug 14 2015 | TKMR | Arbutus Biopharma ... | KARBE FRANK | Director | Option Exercise | A | 9.11 | 7,500 | 68,325 | 7,500 | |
| Aug 14 2015 | TKMR | Arbutus Biopharma ... | HENRIQUES RICHARD C JR | Director | Option Exercise | A | 9.11 | 7,500 | 68,325 | 7,500 | |
| Aug 14 2015 | TKMR | Arbutus Biopharma ... | CONRAD HERBERT J | Director | Option Exercise | A | 9.11 | 7,500 | 68,325 | 7,500 | |
| Apr 08 2015 | TKMR | Arbutus Biopharma ... | HENRIQUES RICHARD C JR | Director | Option Exercise | A | 17.57 | 15,000 | 263,550 | 15,000 | |
| Apr 07 2015 | TKMR | Arbutus Biopharma ... | CONRAD HERBERT J | Director | Option Exercise | A | 17.57 | 15,000 | 263,550 | 15,000 | |
| Apr 02 2015 | TKMR | Arbutus Biopharma ... | Murray Mark J. | President & CEO | Option Exercise | A | 17.57 | 180,000 | 3,162,600 | 180,000 | |
| Apr 02 2015 | TKMR | Arbutus Biopharma ... | Cousins Bruce | Exec VP & CFO | Option Exercise | A | 17.57 | 80,000 | 1,405,600 | 80,000 | |
| Apr 02 2015 | TKMR | Arbutus Biopharma ... | Abrams Michael J. | Exec. VP & Chief Di ... | Option Exercise | A | 17.57 | 50,000 | 878,500 | 50,000 |
Page: 1